These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 34851509)

  • 61. Renal histology in pauci-immune rapidly progressive glomerulonephritis: 8-year retrospective study.
    Minz RW; Chhabra S; Joshi K; Rani L; Sharma N; Sakhuja V; Duggal R; Pasricha N
    Indian J Pathol Microbiol; 2012; 55(1):28-32. PubMed ID: 22499296
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Urinary angiotensinogen: an indicator of active antineutrophil cytoplasmic antibody-associated glomerulonephritis.
    Wu L; Yang M; Feng X; Jin L; Wu C; Cui S; Zhou Z; Zhong X; Shi M; Yang Z; Cao W
    Nephrol Dial Transplant; 2019 May; 34(5):838-847. PubMed ID: 29733413
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CD163 and CD206 expression define distinct macrophage subsets involved in active ANCA-associated glomerulonephritis.
    Aendekerk JP; Jiemy WF; Raveling-Eelsing E; Bijnens N; Abdul-Hamid MA; Strating IM; Dekkema GJ; Sanders JF; Stegeman CA; Damoiseaux JGMC; Little MA; Heeringa P; van Paassen P
    J Autoimmun; 2022 Dec; 133():102914. PubMed ID: 36183584
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis.
    Shah S; Havill J; Rahman MH; Geetha D
    Clin Rheumatol; 2016 Apr; 35(4):953-60. PubMed ID: 26445939
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Development and validation of a renal risk score in ANCA-associated glomerulonephritis.
    Brix SR; Noriega M; Tennstedt P; Vettorazzi E; Busch M; Nitschke M; Jabs WJ; Özcan F; Wendt R; Hausberg M; Sellin L; Panzer U; Huber TB; Waldherr R; Hopfer H; Stahl RAK; Wiech T
    Kidney Int; 2018 Dec; 94(6):1177-1188. PubMed ID: 30385041
    [TBL] [Abstract][Full Text] [Related]  

  • 66. SCG/Kinjoh mice: a model of ANCA-associated crescentic glomerulonephritis with immune deposits.
    Neumann I; Birck R; Newman M; Schnülle P; Kriz W; Nemoto K; Yard B; Waldherr R; Van Der Woude FJ
    Kidney Int; 2003 Jul; 64(1):140-8. PubMed ID: 12787404
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunopathologic co-localization of MPO, IgG, and C3 in glomeruli in human MPO-ANCA-associated glomerulonephritis.
    Kawashima S; Arimura Y; Sano K; Kudo A; Komagata Y; Kaname S; Kawakami H; Yamada A
    Clin Nephrol; 2013 Apr; 79(4):292-301. PubMed ID: 23537682
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical characteristics and outcomes of MPO-ANCA-associated glomerulonephritis with bronchiectasis: A retrospective case-control study.
    Luo L; Li H; Tang J; Liao Z; Wang F; Jin Y; Zhou F; Feng J; Li X
    Semin Arthritis Rheum; 2022 Dec; 57():152082. PubMed ID: 36058136
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neutrophil Gelatinase-Associated Lipocalin Protects from ANCA-Induced GN by Inhibiting T
    Schreiber A; Rousselle A; Klocke J; Bachmann S; Popovic S; Bontscho J; Schmidt-Ott KM; Siffrin V; Jerke U; Ashraf MI; Panzer U; Kettritz R
    J Am Soc Nephrol; 2020 Jul; 31(7):1569-1584. PubMed ID: 32487561
    [TBL] [Abstract][Full Text] [Related]  

  • 70. ANCA-negative pauci-immune renal vasculitis: histology and outcome.
    Eisenberger U; Fakhouri F; Vanhille P; Beaufils H; Mahr A; Guillevin L; Lesavre P; Noël LH
    Nephrol Dial Transplant; 2005 Jul; 20(7):1392-9. PubMed ID: 15855209
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An unusual presentation of propylthiouracil-induced anti-MPO and PR3 positive ANCA vasculitis with associated anti-GBM antibodies, IgA nephropathy and an IgG4 interstitial infiltrate: a case report.
    Galante JR; Daruwalla CP; Roberts ISD; Haynes R; Storey BC; Bottomley MJ
    BMC Nephrol; 2020 Jul; 21(1):295. PubMed ID: 32703233
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Organisation of lymphocytic infiltrates in ANCA-associated glomerulonephritis.
    Brix SR; Noriega M; Herden EM; Goldmann B; Langbehn U; Busch M; Jabs WJ; Steinmetz OM; Panzer U; Huber TB; Stahl RAK; Wiech T
    Histopathology; 2018 Jun; 72(7):1093-1101. PubMed ID: 29453894
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Critical re-evaluation of 41 cases of "idiopathic" crescentic glomerulonephritis.
    Ferrario F; Tadros MT; Napodano P; Sinico RA; Fellin G; D'Amico G
    Clin Nephrol; 1994 Jan; 41(1):1-9. PubMed ID: 8137564
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases.
    Haas M; Eustace JA
    Kidney Int; 2004 Jun; 65(6):2145-52. PubMed ID: 15149327
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Morphologic and immunohistochemical observations in granulomatous glomerulonephritis.
    Bhathena DB; Migdal SD; Julian BA; McMorrow RG; Baehler RW
    Am J Pathol; 1987 Mar; 126(3):581-91. PubMed ID: 3548411
    [TBL] [Abstract][Full Text] [Related]  

  • 76. New advances in the pathogenesis of ANCA-associated vasculitides.
    Chen M; Kallenberg CG
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S108-14. PubMed ID: 19646356
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunohistochemical detection of citrullinated histone H3-positive neutrophils is useful for identifying active glomerular and interstitial lesions in antineutrophil cytoplasmic antibody-associated vasculitis.
    Kimura H; Mii A; Shoji J; Arakawa Y; Shimizu A
    Histopathology; 2021 Mar; 78(4):520-531. PubMed ID: 32956514
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Modified histopathological classification with age-related glomerulosclerosis for predicting kidney survival in ANCA-associated glomerulonephritis.
    Aydın MF; Yıldız A; Oruç A; Aytaç Vuruşkan B; Akgür S; Ayar Y; Güllülü M; Dilek K; Yavuz M; Ortaç H; Ersoy A
    Int Urol Nephrol; 2023 Mar; 55(3):741-748. PubMed ID: 36153782
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Outcome Predictors of Biopsy-Proven Myeloperoxidase-Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.
    Ge Y; Yang G; Yu X; Sun B; Zhang B; Yuan Y; Zeng M; Wang N; Mao H; Xing C
    Front Immunol; 2020; 11():607261. PubMed ID: 33613528
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Anti-neutrophil cytoplasmic antibody associated glomerulonephritis complicating treatment with hydralazine.
    Santoriello D; Bomback AS; Kudose S; Batal I; Stokes MB; Canetta PA; Radhakrishnan J; Appel GB; D'Agati VD; Markowitz GS
    Kidney Int; 2021 Aug; 100(2):440-446. PubMed ID: 33857570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.